跳至主要内容
临床试验/IRCT20090117001556N145
IRCT20090117001556N145尚未招募2 期

Evaluating the efficacy and safety of Saffron add-on treatment in the improvement of motor and depressive symptoms in patients with Parkinson's disease: A randomized, double-blind, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30 years 至 75 years(—)
性别
All

入选标准

  • Diagnosis for Parkinson's disease by Neurologist
  • Diagnosis of depression, mild to moderate according to HAM-D

排除标准

  • Age outside the range of 30-75 years
  • Diagnosis or history of other neurological diseases such as epilepsy and Alzheimer's disease
  • Diagnosis or history of vascular disorders, dementia and stroke
  • Diagnosis or history of other psychiatric disorders such as bipolar disorder
  • Antipsychotic use in the past year
  • Diagnosis of central nervous system infections such as meningitis during the study
  • Use of Linezolid at the beginning of the study, or during the study

研究者

相似试验